EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

TRIM37 mitigates adriamycin-induced nephropathy by promoting PTEN ubiquitination and degradation to suppress mitochondrial apoptosis and podocyte injury

Yu Xin, Xue Yang, Yanning Zhang, Yanhua Jin

Human & Experimental Toxicology · 2026-03 · 45

DOI: 10.1177/09603271261422943 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human & Experimental Toxicology, online erschienen am 14.03.2026. Verfasst von Yu Xin und 3 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Liaoning Province Applied Basic Research Plan Projects.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Podocyte loss or functional impairment is a key event in the pathophysiology of nephrotic syndrome (NS). NS can further progress to chronic kidney disease (CKD) and/or end-stage renal disease (ESRD). This study aimed to explore the potential role and underlying mechanism of TRIM37 in NS.

Methods

Bioinformatics analysis was performed on the GEO dataset GSE97709 to analyze the association between TRIM37 expression and CKD. Adriamycin (ADR)-induced nephropathy models in mice and ADR-exposed human podocytes were used to investigate the function of TRIM37. TRIM37 overexpression experiments were conducted in vivo and in vitro . The binding interaction between TRIM37 and PTEN was verified and the ubiquitination and degradation of PTEN. The activation of the Akt pathway were detected. PTEN overexpression was used to confirm the regulatory relationship with TRIM37.

Results

Both ADR-treated mice and ADR-exposed podocytes showed decreased TRIM37 expression. In vivo , ADR-induced mice exhibited elevated proteinuria, renal dysfunction, and structural damage, which were significantly ameliorated by TRIM37 overexpression. TRIM37 also inhibited ADR-induced cell apoptosis. In vitro , ADR exposure caused podocyte injury, reduced cell viability, and altered mitochondrial membrane potential, while these effects were partially reversed by TRIM37 overexpression. Mechanistically, TRIM37 directly bound to PTEN, promoting its ubiquitination and subsequent degradation, thereby activating the Akt pathway. Furthermore, PTEN overexpression counteracted the protective effects of TRIM37.

Discussion

The findings demonstrate that TRIM37 attenuates ADR-induced nephropathy by inhibiting mitochondrial apoptosis and podocyte injury through the PTEN/Akt signaling pathway. Collectively, these results suggest that TRIM37 may serve as a potential therapeutic target for NS.

Förderung

  • Liaoning Province Applied Basic Research Plan Projects

Zitieren

APA

Xin, Y., Yang, X., Zhang, Y., & Jin, Y. (2026). TRIM37 mitigates adriamycin-induced nephropathy by promoting PTEN ubiquitination and degradation to suppress mitochondrial apoptosis and podocyte injury. Human & Experimental Toxicology, 45. https://doi.org/10.1177/09603271261422943

Vancouver

Xin Y, Yang X, Zhang Y, Jin Y. TRIM37 mitigates adriamycin-induced nephropathy by promoting PTEN ubiquitination and degradation to suppress mitochondrial apoptosis and podocyte injury. Human & Experimental Toxicology. 2026;45. doi:10.1177/09603271261422943

BibTeX
@article{Xin2026,
  author = {Xin, Yu and Yang, Xue and Zhang, Yanning and Jin, Yanhua},
  title = {TRIM37 mitigates adriamycin-induced nephropathy by promoting PTEN ubiquitination and degradation to suppress mitochondrial apoptosis and podocyte injury},
  journal = {Human & Experimental Toxicology},
  year = {2026},
  volume = {45},
  doi = {10.1177/09603271261422943}
}
Kostenlos starten →